Free Submission Public Relations & NewsPR-inside.com
 
DeutschEnglish

Get the latest news
with our RSS feed
rss feed
Add to My Yahoo!
More information
Business

PharmaVigilant Announces Major New Release of Clinical Data Warehouse: I-Warehouse 2.0


Print article Print article
Refer this article Refer to a friend
© Business Wire 2008
2008-07-25 15:52:04 -

www.pharmavigilant.com - PharmaVigilant Alice Resker, 508-898-0095 Marketing aresker@pharmavigilant.com PharmaVigilant, an innovative solution provider in the clinical technology market, announced today the release of a new version of I-Warehouse 2.0.

The new version of I-Warehouse incorporates several new important features that include Data on Demand, incorporation of Meta-Data into the I-Warehouse, as well as the

ability to reconcile and query data issues such as partial dates. Lab imports have been expanded to scale to over 5 million data items per trial instance, without sacrificing speed within the analysis tool (IRT).

Data on Demand has been added to enable our clients to download all of their trial information whenever they want in whatever format that they specify. As I-Warehouse is a multi-trial, cross-trial analysis system, the client can specify Data on Demand on one trial in SAS, and another trial in CDISC SDTM. This eliminates access issues and costs in regards to data exports for all of our client's trials.

Incorporating meta-data into the warehouse enables users to build reports that include the status of the casebook and forms, not just the values of the data. Sponsors can now monitor the progress of their studies in addition to analyzing data trends.

Partial dates are already a feature of the InSpire EDC system and now I-Warehouse can incorporate incomplete dates in searches and sorting.

"Providing Data on Demand to our clients returns the control of the data back to the sponsors, where it belongs. It eliminates the sponsor's issue of not having immediate access to their data, and negates the issue of additional costs associated with obtaining their data." said James DeSanti, CEO of PharmaVigilant. Data on Demand is just not the right thing to do; it's the smart thing to do.

About PharmaVigilant

PharmaVigilant offers unique solutions to address the complexities of global clinical research. The Company focuses on Phase 1-4 clinical trials, registries and other post-marketing studies. PharmaVigilant's suite of products supports over 200,000 patients in 14 countries in North America, Europe, and Asia. All software components are modularized enabling the sponsors, or CRO's, and ARO's to either outsource, or in-source one or all of our modules. Other solutions include InSpire, I-Vault, InSpire Reporting Tool; InSpire Control Center, I-Builder, and PaySite. For more information, please visit the web site at www.pharmavigilant.com.

First in the Industry to Provide Data on Demand (DOD)


Disclaimer: (c) 2007 Business Wire. All of the news releases contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Business Wire's members, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.


Terms & Conditions | About us | Contact PR-inside.com